Nicotine reduction revisited: science and future directions.
Regulation of nicotine levels in cigarettes and other tobacco products is now possible with the passage of the Family Smoking Prevention and Tobacco Control Act (FSPTCA) in 2009, giving the US Food and Drug Administration (FDA) authority to regulate tobacco products, and with Articles 9-11 of the WHO Framework Convention on Tobacco Control. Both regulatory approaches allow establishing product standards for tobacco constituents, including nicotine. The FSPTCA does not allow nicotine levels to be decreased to zero, although the FDA has the authority to reduce nicotine yields to very low, presumably non-addicting levels. The proposal to reduce levels of nicotine to a level that is non-addicting was originally suggested in 1994. Reduction of nicotine in tobacco products could potentially have a profound impact on reducing tobacco-related morbidity and mortality. To examine this issue, two meetings were convened in the US with non-tobacco-industry scientists of varied disciplines, tobacco control policymakers and representatives of government agencies. This article provides an overview of the current science in the area of reduced nicotine content cigarettes and key conclusions and recommendations for research and policy that emerged from the deliberations of the meeting members.
Hatsukami
Dorothy K
DK
Tobacco Use Research Center, University of Minnesota, 717 Delaware St SE, Minneapolis, Minnesota 55414, USA. hatsu001@umn.edu
Perkins
Kenneth A
KA
Lesage
Mark G
MG
Ashley
David L
DL
Henningfield
Jack E
JE
Benowitz
Neal L
NL
Backinger
Cathy L
CL
Zeller
Mitch
M
D000818:Animals; D033161:Government Regulation; D006291:Health Policy; D006801:Humans; D009538:Nicotine / Q000009:adverse effects; D012907:Smoking / Q000009:adverse effects*; D016540:Smoking Cessation; D019460:Tobacco Industry / Q000331:legislation & jurisprudence*; D014029:Tobacco Use Disorder / Q000401:mortality / Q000517:prevention & control*; D014481:United States; D014026:Nicotiana
D009538:Nicotine